{"DataElement":{"publicId":"3536397","version":"1","preferredName":"Lung Carcinoma Diagnosis Name","preferredDefinition":"Text name for the histologic subtype used to refine a diagnosis of lung cancer.","longName":"3536341v1.0:3536386v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3536341","version":"1","preferredName":"Lung Carcinoma Histologic Subtype","preferredDefinition":"A carcinoma originating in the lung.  Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas.  Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas.  Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.A group forming a type within a larger type.","longName":"2190444v1.0:2207639v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2190444","version":"1","preferredName":"Lung Carcinoma","preferredDefinition":"A carcinoma originating in the lung.  Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas.  Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas.  Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors. -- 2004","longName":"C4878","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Carcinoma","conceptCode":"C4878","definition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7D7251C-530B-5E2C-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-01","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207639","version":"1","preferredName":"Histologic Subtype","preferredDefinition":"Of or relating to histology.:Subtype; a group forming a type within a larger type.","longName":"C25526:C25696","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2AE5-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60C12FE-0B9D-1D09-E040-BB89AD434D85","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3536386","version":"1","preferredName":"Lung Carcinoma Histology Diagnosis Name","preferredDefinition":"A carcinoma originating in the lung.  Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas.  Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas.  Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors._Histology is the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._The words or language units by which a thing is known.","longName":"3536386v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Small Cell Lung Cancer","valueDescription":"Small Cell Lung Carcinoma","ValueMeaning":{"publicId":"3297699","version":"1","preferredName":"Small Cell Lung Carcinoma","longName":"3297699","preferredDefinition":"A highly aggressive subtype of lung carcinoma characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Small Cell Carcinoma","conceptCode":"C4917","definition":"A highly aggressive carcinoma with neuroendocrine differentiation arising from the lung. It is characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B035F07A-837C-9251-E040-BB89AD4303FC","latestVersionIndicator":"Yes","beginDate":"2011-10-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-26","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60F1C7A-CFDA-520C-E040-BB89AD433720","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Large Cell Neuroendocrine Carcinoma","valueDescription":"Large Cell Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"2838592","version":"1","preferredName":"Large Cell Neuroendocrine Carcinoma","longName":"2838592","preferredDefinition":"A usually aggressive carcinoma composed of large malignant cells which display neuroendocrine characteristics. It is characterized by the presence of high mitotic activity and necrotic changes. The vast majority of cases are positive for neuron-specific enolase. Representative examples include lung, breast, cervical, and thymic neuroendocrine carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell Neuroendocrine Carcinoma","conceptCode":"C6875","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant large cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A5F1C9-F794-B082-E040-BB89AD436154","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"COOPERM","dateModified":"2018-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60F1C7A-CFE5-520C-E040-BB89AD433720","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Large Cell Carcinoma, Specify","valueDescription":"Large Cell Lung Carcinoma, Specify","ValueMeaning":{"publicId":"3536387","version":"1","preferredName":"Large Cell Lung Carcinoma, Specify","longName":"3536387","preferredDefinition":"Be specific about something; define clearly.: A poorly differentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular or squamous differentiation.  There is a male predilection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung Large Cell Carcinoma","conceptCode":"C4450","definition":"An undifferentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular, squamous, or neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60F1C7A-CFF3-520C-E040-BB89AD433720","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60F1C7A-D00C-520C-E040-BB89AD433720","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Non-Small Cell Lung Cancer Not Otherwise Specified (NOS)","valueDescription":"Non-Small Cell Lung Cancer, Not Otherwise Specified ","ValueMeaning":{"publicId":"3536389","version":"1","preferredName":"Non-Small Cell Lung Cancer, Not Otherwise Specified ","longName":"3536389v1.00","preferredDefinition":"A carcinoma characterized by the presence of large adenocarcinoma cells._A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors._Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Small Cell Adenocarcinoma","conceptCode":"C27745","definition":"A carcinoma characterized by the presence of large adenocarcinoma cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Lung Carcinoma","conceptCode":"C4878","definition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60F1C7A-D01B-520C-E040-BB89AD433720","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60F1C7A-D034-520C-E040-BB89AD433720","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":"Lung Adenocarcinoma","ValueMeaning":{"publicId":"3106713","version":"1","preferredName":"Lung Adenocarcinoma","longName":"3106713","preferredDefinition":"A carcinoma characterized by the presence of malignant glandular epithelial cells.  There is a male predilection with a male to female ratio of 2:1.  Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding.  If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever.  Tobacco smoke is a known risk factor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Adenocarcinoma","conceptCode":"C3512","definition":"A carcinoma that arises from the lung and is characterized by the presence of malignant glandular epithelial cells.  There is a male predilection with a male to female ratio of 2:1.  Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding.  If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever.  Tobacco smoke is a known risk factor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883834AB-0D4B-C6A6-E040-BB89AD431A8D","latestVersionIndicator":"Yes","beginDate":"2010-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60F1C7A-D048-520C-E040-BB89AD433720","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma","valueDescription":"Squamous Cell Lung Carcinoma","ValueMeaning":{"publicId":"2956083","version":"1","preferredName":"Squamous Cell Lung Carcinoma","longName":"2956083","preferredDefinition":"A carcinoma arising from malignant squamous bronchial epithelial cells and characterized by the presence of keratinization and/or intercellular bridges.  Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma","conceptCode":"C3493","definition":"A carcinoma arising from squamous bronchial epithelial cells. It may be keratinizing or non-keratinizing. Keratinizing squamous cell carcinoma is characterized by the presence of keratinization, pearl formation, and/or intercellular bridges. Non-keratinizing squamous cell carcinoma is characterized by the absence of keratinization, pearl formation, and intercellular bridges. Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76EBECE2-B835-A0E2-E040-BB89AD435984","latestVersionIndicator":"Yes","beginDate":"2009-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60F1C7A-D05D-520C-E040-BB89AD433720","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","deletedIndicator":"No"},{"value":"Micropapillary","valueDescription":"Micropapillary Lung Carcinoma","ValueMeaning":{"publicId":"5438631","version":"1","preferredName":"Micropapillary Lung Carcinoma","longName":"5438631","preferredDefinition":"An aggressive variant of lung adenocarcinoma that exhibits a micropapillary architectural pattern. The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Micropapillary Adenocarcinoma","conceptCode":"C128847","definition":"An aggressive variant of lung adenocarcinoma that exhibits a micropapillary architectural pattern. The prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B3E30C9-260A-9745-E050-BB89AD432A67","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3E30C9-2623-9745-E050-BB89AD432A67","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Bronchoalveolar, NOS","valueDescription":"Bronchioloalveolar, NOS","ValueMeaning":{"publicId":"5438632","version":"1","preferredName":"Bronchioloalveolar, NOS","longName":"5438632","preferredDefinition":"Not characterized in any other way.::1: A well or moderately differentiated morphologic variant of lung adenocarcinoma characterized by tumor growth along the alveolar structures without stromal, vascular, or pleural invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Minimally Invasive Lung Adenocarcinoma","conceptCode":"C2923","definition":"A solitary adenocarcinoma arising from the lung and measuring 3 cm or less in size. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B3E30C9-262D-9745-E050-BB89AD432A67","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3E30C9-2646-9745-E050-BB89AD432A67","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Solid","valueDescription":"Solid Neoplasm","ValueMeaning":{"publicId":"5438011","version":"1","preferredName":"Solid Neoplasm","longName":"5438011","preferredDefinition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B3C588B-6791-0A60-E050-BB89AD432BC1","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3C588B-67AA-0A60-E050-BB89AD432BC1","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Papillary","valueDescription":"Papillary Lung Adenocarcinoma","ValueMeaning":{"publicId":"2956080","version":"1","preferredName":"Papillary Lung Adenocarcinoma","longName":"2956080","preferredDefinition":"A morphologic variant of lung adenocarcinoma characterized by the presence of papillary structures.  (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Papillary Adenocarcinoma","conceptCode":"C5650","definition":"A morphologic variant of lung adenocarcinoma characterized by the presence of papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76EBECE2-B7E8-A0E2-E040-BB89AD435984","latestVersionIndicator":"Yes","beginDate":"2009-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3C588B-67D7-0A60-E050-BB89AD432BC1","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Acinar","valueDescription":"Acinar Lung Adenocarcinoma","ValueMeaning":{"publicId":"2956082","version":"1","preferredName":"Acinar Lung Adenocarcinoma","longName":"2956082","preferredDefinition":"A morphologic variant of lung adenocarcinoma characterized by the presence of acinar structures composed of columnar or cuboidal cells. (NCI05)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Acinar Adenocarcinoma","conceptCode":"C5649","definition":"A morphologic variant of lung adenocarcinoma characterized by the presence of acinar structures composed of columnar or cuboidal cells. (NCI05)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76EBECE2-B80E-A0E2-E040-BB89AD435984","latestVersionIndicator":"Yes","beginDate":"2009-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3C588B-67E2-0A60-E050-BB89AD432BC1","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Invasive adenocarcinoma","valueDescription":"Invasive Adenocarcinoma","ValueMeaning":{"publicId":"4117371","version":"1","preferredName":"Invasive Adenocarcinoma","longName":"4117371","preferredDefinition":"Marked by a tendency to spread, especially into healthy surrounding tissue.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FCE4EA-4A4C-BBE9-E040-BB89AD430980","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3C588B-67ED-0A60-E050-BB89AD432BC1","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Adenosquamous","valueDescription":"Adenosquamous Lung Carcinoma","ValueMeaning":{"publicId":"5438013","version":"1","preferredName":"Adenosquamous Lung Carcinoma","longName":"5438013","preferredDefinition":"An aggressive carcinoma with a poor prognosis characterized by a presence of both malignant squamous cells and glandular cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Adenosquamous Carcinoma","conceptCode":"C9133","definition":"An aggressive carcinoma with a poor prognosis characterized by a presence of both malignant squamous cells and glandular cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B3C588B-67FA-0A60-E050-BB89AD432BC1","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3C588B-6813-0A60-E050-BB89AD432BC1","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Invasive mucinous adenocarcinoma","valueDescription":"Invasive Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"5438014","version":"1","preferredName":"Invasive Mucinous Adenocarcinoma","longName":"5438014","preferredDefinition":"Marked by a tendency to spread, especially into healthy surrounding tissue.: containing or resembling mucin.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mucinous","conceptCode":"C14163","definition":"Containing or resembling mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B3C588B-6821-0A60-E050-BB89AD432BC1","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3C588B-683A-0A60-E050-BB89AD432BC1","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Lepidic predominant adenocarcinoma","valueDescription":"Lepidic Predominant Adenocarcinoma","ValueMeaning":{"publicId":"5427576","version":"1","preferredName":"Lepidic Predominant Adenocarcinoma","longName":"5427576","preferredDefinition":"A lung adenocarcinoma characterized by the presence of mildly and moderately differentiated adenocarcinoma cells across the alveolar walls with at least one focus of invasive carcinoma measuring more than 5 mm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lepidic Adenocarcinoma","conceptCode":"C123160","definition":"A lung adenocarcinoma characterized by the presence of mildly and moderately differentiated adenocarcinoma cells across the alveolar walls with at least one focus of invasive carcinoma measuring more than 5 mm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A9E0F70-7B3F-007D-E050-BB89AD436985","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3C588B-684E-0A60-E050-BB89AD432BC1","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Minimally invasive adenocarcinoma","valueDescription":"Minimum Invasive Adenocarcinoma","ValueMeaning":{"publicId":"5438015","version":"1","preferredName":"Minimum Invasive Adenocarcinoma","longName":"5438015","preferredDefinition":"The smallest possible quantity.: Marked by a tendency to spread, especially into healthy surrounding tissue.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimum","conceptCode":"C25570","definition":"The smallest possible quantity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B3C588B-685D-0A60-E050-BB89AD432BC1","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3C588B-6876-0A60-E050-BB89AD432BC1","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Bronchoalveolar carcinoma/AIS, mucinous","valueDescription":"Mucinous Bronchioloalveolar Carcinoma","ValueMeaning":{"publicId":"5438094","version":"1","preferredName":"Mucinous Bronchioloalveolar Carcinoma","longName":"5438094","preferredDefinition":"A morphologic variant of minimally invasive lung adenocarcinoma characterized by tall columnar cells and mucin production.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimally Invasive Lung Mucinous Adenocarcinoma","conceptCode":"C7268","definition":"A morphologic variant of minimally invasive lung adenocarcinoma characterized by tall columnar cells and mucin production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B3C588B-689E-0A60-E050-BB89AD432BC1","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"COOPERM","dateModified":"2018-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3C588B-68B7-0A60-E050-BB89AD432BC1","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"},{"value":"Bronchoalveolar carcinoma/AIS, non-mucinous","valueDescription":"Non-Mucinous Bronchioloalveolar Carcinoma","ValueMeaning":{"publicId":"5210953","version":"1","preferredName":"Non-Mucinous Bronchioloalveolar Carcinoma","longName":"5210953","preferredDefinition":"A morphologic variant of bronchiolo-alveolar lung carcinoma characterized by the presence of Clara cells and/or type II cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimally Invasive Lung Non-Mucinous Adenocarcinoma","conceptCode":"C7269","definition":"A morphologic variant of minimally invasive lung  adenocarcinoma characterized by the presence of Clara cells and/or type II cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C8CA-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3B3C588B-68CB-0A60-E050-BB89AD432BC1","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"ONEDATA","dateModified":"2016-08-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3536385","version":"1","preferredName":"Lung Carcinoma Histologic Test Diagnosis Name","preferredDefinition":"A carcinoma originating in the lung.  Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas.  Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas.  Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors. -- 2004:A diagnostic test used to examine and define microscopic tissue structure, composition, or etiology. The test results are often used by a clinician to diagnose disease or disordered function.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:The words or language units by which a thing is known.","longName":"C4878:C49131:C15220:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Carcinoma","conceptCode":"C4878","definition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Histologic Test","conceptCode":"C49131","definition":"A diagnostic test used to examine and define microscopic tissue structure, composition, or etiology. The test results are often used by a clinician to diagnose disease or disordered function.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60F1C7A-CFAA-520C-E040-BB89AD433720","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"ONEDATA","dateModified":"2012-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60F1C7A-CFBB-520C-E040-BB89AD433720","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":"2023.8.28 Updated PV def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5655968","version":"1","longName":"HTMCP (HIV+Tumor Molecular Characterization Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000067","version":"1","longName":"HTMCP","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Diagnosis (Lung Cancer)","type":"Preferred Question Text","description":"Diagnosis (Lung Cancer)","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60F1C7A-D18A-520C-E040-BB89AD433720","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"TSESU","dateModified":"2017-02-09","changeDescription":"Curated for HTMCP Initiative","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}